Lotta Hansson
9PUBLICATIONS
34CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Apr 01, 2026
AVD is an effective chemotherapy backbone in first-line treatment of older patients with classical Hodgkin lymphoma.Ninja Övergaard, Kjersti Lia, Jeremia Collin
|Feb 21, 2025
Outcomes of the COVID-19 pandemic in chronic lymphocytic leukemia: focus on the very early period and Omicron era.Pontus Hedberg, Lisa Blixt, Sandra Eketorp Sylvan
|Aug 11, 2023
Incidence of cardiovascular and bleeding events and reasons for discontinuation in patients with chronic lymphocytic leukemia treated with ibrutinib-A retrospective analysis on consecutive patients from a well-defined region.Maria L Andersson, Hemming Johansson, Anders Österborg
|Jul 28, 2023
Idelalisib (PI3Kδ inhibitor) therapy for patients with relapsed/refractory chronic lymphocytic leukemia: A Swedish nation-wide real-world report on consecutively identified patients.Agnes Mattsson, Sandra Eketorp Sylvan, Per Axelsson
|Jul 18, 2022
Temporary cessation of ibrutinib results in reduced grade 3-4 infections and durable remissions-Interim analysis of an on-off-repeat Phase 1b/2 study in patients with chronic lymphocytic leukemia.Jeanette Lundin, Tom A Mulder, Magdalena Kättström
|Sep 26, 2021
Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B- and T-cell immunity during 13 months in consecutive patients.Lisa Blixt, Gordana Bogdanovic, Marcus Buggert
Pageof 2
Frequent Collaborators
3 joint publications
Marzia Palma
2 joint publications
Tom A Mulder
2 joint publications
Anders Österborg
2 joint publications
Peter Nilsson
2 joint publications
Margaret Sällberg Chen
1 joint publications
Fariba Mozaffari
1 joint publications
Håkan Mellstedt
1 joint publications
Maria Winqvist
1 joint publications
Sara Mravinacova
1 joint publications
C I Edvard Smith
